• Applied Biological Chemistry
• /
• 제33권4호
• /
• pp.287-292
• /
• 1990

황금종 대두로 부터 8종의 Bowman-Birk형 proteinase inhibitor들을 DEAE-Sephadex A-50으로 전기영동상 단일 band로 순수하게 분리하였다. 이중 inhibitor VII cysteine함량이 17%로 높고 trypsin 및 chymotrypsin에 대해 각각 독립적인 결합부위를 가지고 있으며 상기 두 효소에 대한 저해활성도의 비(TIA/CIA)가 1.0으로 전형적인 Bowman-Birk trypsin inhibitor(BBTI)로 확인되었다. 본 inhibitor와 trypsin 및 chymotrypsin complex의 dissociation constant는 각각 $9.17{\times}10^{-9}M$과 $5.14{\times}10^{-8}M$로 매우 안정하였다. 또한 inhibitor Vll은 열에 매우 안정한 단백질로 $100^{\circ}C$, 6시간 처리에도 저해활성도 감소가 50%밖에 안되었다. 순수분리된 7종의 다른 isoinhibitor중 inhibitor III만이 TIA/CIA값이 1.2로 BBTI와 비슷하였으나 그외 inhibitor I, II, IV, V,및 VIII은 그 값이 $3{\sim}29$로 BBTI와는 성질이 다른 isoinhibitnr로 추정되었다.

• Applied Biological Chemistry
• /
• 제42권4호
• /
• pp.310-316
• /
• 1999

대두가공제품 중에 존재하는 Bowman-Birk protease inhibitor(BBPI) 함량을 protease 저해활성 측정 및 경합 Enzyme-Linked Immunosorbent Assay(ELISA)로 살펴보았다. 항체제조를 위한 BBPI는 ion exchange chromatography와 전기영동 후 gel slicing 방법으로 시판 soybean trypsin-chymotrypsin inhibitor로부터 순수, 분리하였다. 순수분리한 BBPI를 면역원으로 rabbit anti-BBPI antibody를 조제하였으며 단백질 농도별 titration방법으로 BBP에 비교적 선택적으로 결합하는 항체임을 확인하였다. 이를 이용한 경합 ELISA 방법으로 BBPI를 정량하기 위한 표준 정량곡선을 작성하였으며 시료용액중의 BBPI 함량이 $0.03{\sim}30\;{\mu}g/ml$ 범위일 경우에 정량적인 분석이 가능하였다. 대두품종별 chymotrypsin 저해활성은 $8,462{\sim}12,428\;U/g$이었으며 BBPI 함량은 $482{\sim}692\;mg%$ 이었다. 시판 대두 가공제품 중에서 5종의 콩나물은 건물량 기준으로 $10,695{\sim}13,249\;U/g$의 chymotrypsin 저해활성과 $529{\sim}803\;mg%$의 BBPI 함량을 나타내었으며 일부 두부제품에서도 68.9 mg%정도의 BBPI가 검출되었다. 그 밖의 두유, 된장, 고추장 및 간장 등의 대두발효식품, 탈지대두박 등에서는 chymotrypsin 저해활성 및 BBPI가 거의 검출되지 않았다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권4호
• /
• pp.1097-1104
• /
• 2012

Background/Aim: Pristimerin isolated from Celastrus and Maytenus spp can inhibit proteasome activity. However, whether pristimerin can modulate cancer metastasis is unknown. Methods: The impacts of pristimerin on the purified and intracellular chymotrypsin proteasomal activity, the levels of regulator of G protein signaling 4 (RGS 4) expression and breast cancer cell lamellipodia formation, and the migration and invasion were determined by enzymatic, Western blot, immunofluorescent, and transwell assays, respectively. Results: We found that pristimerin inhibited human chymotrypsin proteasomal activity in MDA-MB-231 cells in a dose-dependent manner. Pristimerin also inhibited breast cancer cell lamellipodia formation, migration, and invasion in vitro by up-regulating RGS4 expression. Thus, knockdown of RGS4 attenuated pristimerin-mediated inhibition of breast cancer cell migration and invasion. Furthermore, pristimerin inhibited growth and invasion of implanted breast tumors in mice. Conclusion: Pristmerin inhibits proteasomal activity and increases the levels of RGS4, inhibiting the migration and invasion of breast cancer cells.

• The Korean Journal of Ecology
• /
• 제22권1호
• /
• pp.45-50
• /
• 1999

김치 발효 초기에 bacteriocin 생성 유산균을 분리하고자 하였다. 분리 유산균은 형태, 배양 및 생리학적인 특징과 16S rDNA의 부분적인 염기서열로부터 Lactococcus lactis로 동정되었다. 분리균주가 생성한 bacteriocin은 Listeria monocytogenes, Staphylococcus aureus와 같은 그람 양성 병원성 세균과 몇몇 유산균에 대해 항균활성이 있었고, 그람음성균인 Yesinia에는 활성이 없었다. bacteriocin의 활성은 protease, protease ⅩⅣ, a-chymotrypsin과 pepsin에 대해서 활성이 소실되었으나, lipase, trypsin, lysozyme에 대해서는 활성이 유지되었다. bacteriocin의 활성은 pH 2∼11에서 안정적이며 l00℃에서 10분간 열처리시에도 변하지 않았다. 따라서 L. monocytogenes는 발효초기에 L. lactis에 의하여 억제될 수 있다.

• Bulletin of the Korean Chemical Society
• /
• 제35권12호
• /
• pp.3571-3575
• /
• 2014

Proteasome, a multicatalytic protease complex, has been validated as a promising therapeutic target in oncology. Carfilzomib (Kyprolis$^{(R)}$), a tetrapeptide epoxyketone, irreversibly inhibits the chymotrypsin-like (CT-L) activity of the proteasome and has been recently approved for multiple myeloma treatment by FDA. A chemistry effort was initiated to discover the compounds that are reversibly inhibit the proteasome by replacing the epoxyketone moiety of carfilzomib with a variety of ketones as reversible and covalent warheads at the C-terminus. The newly synthesized compounds exhibited significant inhibitory activity against CT-L activity of the human 20S proteasome. When the compounds were tested for cancer cell viability, 14-8 was found to be most potent in inhibiting Molt-4 acute lymphoblastic leukemia cell line with a $GI_{50}$ of $4.4{\mu}M$. Cytotoxic effects of 14-8 were further evaluated by cell cycle analysis and Western blotting, demonstrating activation of apoptotic pathways.

• Fisheries and Aquatic Sciences
• /
• 제19권10호
• /
• pp.42.1-42.10
• /
• 2016

The objectives of this study were to identify the histamine-forming bacteria and bacteriocin- producing lactic acid bacteria (LAB) isolated from Myeolchi-jeot according to sequence analysis of the 16S rRNA gene, to evaluate the inhibitory effects of the bacteriocin on the growth and histamine accumulation of histamine-forming bacteria, and to assess the physico-chemical properties of the bacteriocin. Based on 16S rRNA gene sequences, histamine-forming bacteria were identified as Bacillus licheniformis MCH01, Serratia marcescens MCH02, Staphylococcus xylosus MCH03, Aeromonas hydrophila MCH04, and Morganella morganii MCH05. The five LAB strains identified as Pediococcus acidilactici MCL11, Leuconostoc mesenteroides MCL12, Enterococcus faecium MCL13, Lactobacillus sakei MCL14, and Lactobacillus acidophilus MCL15 were found to produce an antibacterial compound with inhibitory activity against the tested histamine-producing bacteria. The inhibitory activity of these bacteriocins obtained from the five LAB remained stable after incubation at pH 4.0-8.0 and heating for 10 min at $80^{\circ}C$; however, the bacteriocin activity was destroyed after treatment with papain, pepsin, proteinase K, ${\alpha}$-chymotrypsin, or trypsin. Meanwhile, these bacteriocins produced by the tested LAB strains also exhibited histamine-degradation ability. Therefore, these antimicrobial substances may play a role in inhibiting histamine formation in the fermented fish products and preventing seafood-related food-borne disease caused by bacterially generated histamine.

• Journal of Microbiology and Biotechnology
• /
• 제19권11호
• /
• pp.1393-1400
• /
• 2009

A bacteriocin-producing strain PI80 was isolated from the gut of Penaeus indicus (Indian white shrimp) and identified as Streptococcus phocae PI80. The bacteriocin was purified from a culture supernatant to homogeneity as confirmed by Tricine SDS-PAGE. Reverse-phase HPLC analysis revealed a single active fraction eluted at 12.94 min, and MALDI-TOF mass spectrometry analysis showed the molecular mass to be 9.244 kDa. This molecular mass does not correspond to previously described streptococcal bacteriocins. The purified bacteriocin was named phocaecin PI80 from its producer strain, as this is the first report of bacteriocin production by Streptococcus phocae. The bacteriocin exhibited a broad spectrum of activity and inhibited important pathogens: Listeria monocytogenes, Vibrio parahaemolyticus, and V. fischeri. The antibacterial substance was also sensitive to proteolytic enzymes: trypsin, protease, pepsin, and chymotrypsin, yet insensitive to catalase, peroxidase, and diastase, confirming that the inhibition was due to a proteinaceous molecule (i.e., the bacteriocin), and not due to hydrogen peroxide or diacetyl. Phocaecin PI80 moderately tolerated heat treatment (up to $70^{\circ}C$ for 10 min) and resisted certain solvents (acetone, ethanol, and butanol). A massive leakage of $K^+$ ions from E. coli $DH5\alpha$, L. monocytogenes, and V. parahaemolyticus was induced by phocaecin PI80, as measured by Inductively Coupled Plasma Optical Emission Spectrometry (ICPOES). Therefore, the results of this study show that phocaecin PI80 may be a useful tool for inhibiting L. monocytogenes in seafood products that do not usually undergo adequate heat treatment, whereas the cells of Streptococcus phocae PI80 could be used to control vibriosis in shrimp farming.